Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Cheektowaga, NY
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
mi
from
Cheektowaga, NY
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Morehead City, NC
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Morehead City, NC
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Winston-Salem, NC
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Toledo, OH
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Oklahoma City, OK
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Bala-Cynwyd, PA
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
mi
from
Bala-Cynwyd, PA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Houston, TX
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Edegem,
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
mi
from
Edegem,
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Beverly Hills, CA
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Bronx, NY
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Vitamin D Repletion in Primary Hyperparathyroidism
Randomized Controlled Trial of Vitamin D Repletion Regimens in Primary Hyperparathyroidism
Status: Enrolling
Updated:  3/15/2018
mi
from
New York, NY
Vitamin D Repletion in Primary Hyperparathyroidism
Randomized Controlled Trial of Vitamin D Repletion Regimens in Primary Hyperparathyroidism
Status: Enrolling
Updated: 3/15/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Reducing Postoperative Catheterization
Reducing Postoperative Catheterization After Urogynecology Surgery: A Randomized Trial
Status: Enrolling
Updated:  3/15/2018
mi
from
Chapel Hill, NC
Reducing Postoperative Catheterization
Reducing Postoperative Catheterization After Urogynecology Surgery: A Randomized Trial
Status: Enrolling
Updated: 3/15/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
NAC Trial for Anosmia
Pilot Study of Topical Intranasal N-acetyl Cysteine Administration for the Treatment of Anosmia
Status: Enrolling
Updated:  3/16/2018
mi
from
Miami, FL
NAC Trial for Anosmia
Pilot Study of Topical Intranasal N-acetyl Cysteine Administration for the Treatment of Anosmia
Status: Enrolling
Updated: 3/16/2018
University of Miami, Miller School of Medicine, Clinical Research Building
mi
from
Miami, FL
Click here to add this to my saved trials
Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men
Effect of Prostatic Urethral Lift (PUL) Versus Prostate Arterial Embolization (PAE),Novel Minimally Invasive Treatment Options on Health-related Quality of Life (HRQoL) in Men With Lower Urinary Tract Symptoms Secondary to BPH.
Status: Enrolling
Updated:  3/16/2018
mi
from
Saint Louis, MO
Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men
Effect of Prostatic Urethral Lift (PUL) Versus Prostate Arterial Embolization (PAE),Novel Minimally Invasive Treatment Options on Health-related Quality of Life (HRQoL) in Men With Lower Urinary Tract Symptoms Secondary to BPH.
Status: Enrolling
Updated: 3/16/2018
Saint Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms
Urinary Nerve Growth Factor as a Biomarker for Medical Treatment of Male Lower Urinary Tract Symptoms: A Pilot Trial
Status: Enrolling
Updated:  3/19/2018
mi
from
Houston, TX
Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms
Urinary Nerve Growth Factor as a Biomarker for Medical Treatment of Male Lower Urinary Tract Symptoms: A Pilot Trial
Status: Enrolling
Updated: 3/19/2018
Methodist Hospital System
mi
from
Houston, TX
Click here to add this to my saved trials
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome
Status: Enrolling
Updated:  3/19/2018
mi
from
Orange, CA
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome
Status: Enrolling
Updated: 3/19/2018
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Vitamin D Repletion and Maintenance in IBD: How Much and How Often
A Vitamin D Dosing Strategy for Adequate Repletion and Maintenance in IBD Patients With Minimal Disease Activity
Status: Enrolling
Updated:  3/19/2018
mi
from
Los Angeles, CA
Vitamin D Repletion and Maintenance in IBD: How Much and How Often
A Vitamin D Dosing Strategy for Adequate Repletion and Maintenance in IBD Patients With Minimal Disease Activity
Status: Enrolling
Updated: 3/19/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Human Brain Antioxidants During Oxidative Stress
Noninvasive Antioxidant Quantification in the Human Brain Under Oxidative Stress
Status: Enrolling
Updated:  3/20/2018
mi
from
Minneapolis, MN
Human Brain Antioxidants During Oxidative Stress
Noninvasive Antioxidant Quantification in the Human Brain Under Oxidative Stress
Status: Enrolling
Updated: 3/20/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Human Brain Antioxidants During Oxidative Stress
Noninvasive Antioxidant Quantification in the Human Brain Under Oxidative Stress
Status: Enrolling
Updated:  3/20/2018
mi
from
Minneapolis, MN
Human Brain Antioxidants During Oxidative Stress
Noninvasive Antioxidant Quantification in the Human Brain Under Oxidative Stress
Status: Enrolling
Updated: 3/20/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
TEACH: Technology Evaluation to Address Child Health
TEACH: Technology Evaluation to Address Child Health
Status: Enrolling
Updated:  3/20/2018
mi
from
Boston, MA
TEACH: Technology Evaluation to Address Child Health
TEACH: Technology Evaluation to Address Child Health
Status: Enrolling
Updated: 3/20/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Vitamin D Replacement After Kidney Transplant
Vitamin D Replacement After Kidney Transplant
Status: Enrolling
Updated:  3/21/2018
mi
from
Omaha, NE
Vitamin D Replacement After Kidney Transplant
Vitamin D Replacement After Kidney Transplant
Status: Enrolling
Updated: 3/21/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
RAD 1203: Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer
Status: Enrolling
Updated:  3/21/2018
mi
from
Birmingham, AL
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
RAD 1203: Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer
Status: Enrolling
Updated: 3/21/2018
Hazelrig-Salter Radiation Oncology Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Treatment of Rett Syndrome With Recombinant Human IGF-1
Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)
Status: Enrolling
Updated:  3/23/2018
mi
from
Boston, MA
Treatment of Rett Syndrome With Recombinant Human IGF-1
Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)
Status: Enrolling
Updated: 3/23/2018
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis
A Randomized Pilot Trial of Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis
Status: Enrolling
Updated:  3/23/2018
mi
from
Houston, TX
Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis
A Randomized Pilot Trial of Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis
Status: Enrolling
Updated: 3/23/2018
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Community-Led Action Research in Oncology: Improving Symptom Management
Community-Led Action Research in Oncology: Improving Symptom Management
Status: Enrolling
Updated:  3/23/2018
mi
from
Lebanon, NH
Community-Led Action Research in Oncology: Improving Symptom Management
Community-Led Action Research in Oncology: Improving Symptom Management
Status: Enrolling
Updated: 3/23/2018
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Community-Led Action Research in Oncology: Improving Symptom Management
Community-Led Action Research in Oncology: Improving Symptom Management
Status: Enrolling
Updated:  3/23/2018
mi
from
San Pedro Sula,
Community-Led Action Research in Oncology: Improving Symptom Management
Community-Led Action Research in Oncology: Improving Symptom Management
Status: Enrolling
Updated: 3/23/2018
La Liga Contra el Cancer
mi
from
San Pedro Sula,
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Status: Enrolling
Updated:  3/23/2018
mi
from
San Antonio, TX
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Status: Enrolling
Updated: 3/23/2018
Road Runner Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Status: Enrolling
Updated:  3/23/2018
mi
from
Herndon, VA
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
A 10-Week, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Status: Enrolling
Updated: 3/23/2018
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
Caregiver Burden and Distress in Hematopoeitic Stem Cell Transplant
The Impact of Hematopoeitic Stem Cell Transplantation on Primary Caregiver Level of Burden and Distress
Status: Enrolling
Updated:  3/27/2018
mi
from
Atlanta, GA
Caregiver Burden and Distress in Hematopoeitic Stem Cell Transplant
The Impact of Hematopoeitic Stem Cell Transplantation on Primary Caregiver Level of Burden and Distress
Status: Enrolling
Updated: 3/27/2018
Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Maximizing Language Development in Children With Hearing Loss
Pre-Implantation Communication Treatment for Children With Hearing Loss
Status: Enrolling
Updated:  3/27/2018
mi
from
Evanston, IL
Maximizing Language Development in Children With Hearing Loss
Pre-Implantation Communication Treatment for Children With Hearing Loss
Status: Enrolling
Updated: 3/27/2018
Northwestern University
mi
from
Evanston, IL
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Los Angeles, CA
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
San Francisco, CA
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Stanford, CA
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
New Haven, CT
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Miami, FL
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Hinsdale, IL
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Adventist Hinsdale Hospital
mi
from
Hinsdale, IL
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Indianapolis, IN
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Boston, MA
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Boston, MA
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Brooklyn, NY
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
NY Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Mineola, NY
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Madonna Perinatal
mi
from
Mineola, NY
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
New York, NY
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Carnegie Imaging for Women
mi
from
New York, NY
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
New York, NY
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Montefiore Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
New York, NY
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
New York, NY
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Chapel Hill, NC
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Charlotte, NC
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Portland, OR
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Allentown, PA
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
Lehigh Valley Hospital
mi
from
Allentown, PA
Click here to add this to my saved trials
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated:  3/28/2018
mi
from
Columbia, SC
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial (PreNATUS)
Status: Enrolling
Updated: 3/28/2018
University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials